|
Market Cap (4-Jul) $117,644,148,736 (6th) |
Close (30-Jun) $277.38 |
Volume (30-Jun) 970,129 |
Shortsold (19-Jun) 1,827,603 (0.38%) (339th) |
|
52w High $308.82 |
52w Low $228.61 |
P/E 32.47 |
EPS 8.29 |
CSL released this announcement to the ASX on 4 November 2022, 14:49. The announcement is not marked as price sensitive, and is 7 page(s) in length and 26.53kb in size.
You can view all announcements from CSL and see how they appear on a price chart on the announcements page.
At the date of this announcement, CSL was 0.578% short sold according to ASIC data. It was ranked the 317th most shorted stock on the ASX. It remains ranked 339th as of the latest reported data (19 June 2025).
| Other Recent Announcements from CSL | |
|---|---|
| Market Update | 14 June 2023, 7:56 |
| Notification of cessation of securities - CSL | 8 June 2023, 12:12 |
| Shareholder Briefing | 29 May 2023, 9:26 |
| Notification regarding unquoted securities - CSL | 4 November 2022, 14:49 |
| CSL Highlights Progress Across Strong R&D Pipeline | 3 November 2022, 8:16 |
| Licence Agreement - Next Generation mRNA Vaccine Technology | 2 November 2022, 8:47 |
| CSL Notice of Research & Development Investor Briefing | 31 October 2022, 9:50 |
You must be logged in to post a reply.
CSL 